B. L. Goh, A. Soraya, A. Goh, and K. L. Ang, International Journal of Nephrology "Cost-Effectiveness Analysis for the Treatment of Hyperphosphatemia in Predialysis Patients: Calcium-Based versus Noncalcium-Based Phosphate Binders," International Journal of Nephrology, vol. 2018, Article ID 2138528, 7 pages, 2018. https://doi.org/10.1155/2018/2138528/.

Feisul IM., Azmi S, Mohd Rizal AM., Zanariah H, Nik Mahir NJ., Fatanah I, Aizuddin AN., Goh A. What are the direct medical costs of managing Type 2 Diabetes Mellitus in Malaysia? Med J Malaysia 2017; 72(5): 271-277

Azmi S, Goh A, Muhammad NA., Tohid H, A Rashid MR. The Cost and Quality-of-Life of Malaysian Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease and Anemia. Value in Health Regional Issues 2018; 15: 42-49.

Azmi S, Aljunid SM, Maimaiti N, Ali AA, Muhammad Nur A, De Rosas-Valera M, Encluna J, Mohamed R, Wibowo B, Komaryani K, Roberts C. Assessing the Burden of Pneumonia Using Administrative Data from Malaysia, Indonesia, and the Philippines. International Journal of Infectious Diseases 2016; 49: 87-93.

Lee WC., Haron MR., Yu KL., Chong FLT., Goh A., Azmi S. Economic Analysis of Intravenous vs. Subcutaneously Administered Trastuzumab for the Treatment of HER2+ Early Breast Cancer in Malaysia. Advances in Breast Cancer Research 2016; 5(1): 1-13.

Bavanandan S., Yap YC., Ahmad G., Wong HS., Azmi S., Goh A. The Cost and Utility of Renal Transplantation in Malaysia. Transplantation Direct 2015; 1(10): e45.

Milea D., Azmi S., Reginald., Verpillat P., Francois C. A Review of Accessibility Administrative Healthcare Databases in the Asia-Pacific Region. Journal of Market Access and Health Policy 2015; 3: 1-11.

Azmi S., Goh A., Fong A., Anchah L. Quality of Life among Patients with Acute Coronary Syndrome in Malaysia. Value in Health Regional Issues 2015; 6: 80-83.

Azmi S. and Reginald P. Experience and Cost of Pediatric Gastroenteritis to Families: a Survey of Malaysian and Vietnamese Parents. Journal of Gastroenterology, Pancreatology and Liver Disorder 2015; 2(1): 1-8.

Mark B.Y.T., Leong K.F., Ou L.S., Munasir Z., Parekh P.R., Azmi S., Low W.H.H., Goh A. Cost-effectiveness study of pediatric atopic dermatitis in Asia: atopiclair vs. regular emollient (AD-ATOP). Journal of drugs in dermatology. 2015; 14(2): 169-175.

Aljunid S., Maimaiti N., Ahmed Z., Nur A.M., Isa Z.M., Soraya A., Sulong S. Economic Impact of Pneumococcal Protein-D Conjugate Vaccine (PHiD-CV) on the Malaysian National Immunization Programme. Value in Health Regional Issues. 2014; 3: 146-155.

Ramli S.A., Sharmila L., Jamaiyah H., Sharmini S., Tong F.S., Mohamad-Adam B., Low W.H.H. et al. Study protocol of EMPOWER Participatory Action Research (EMPOWER-PAR): a Pragmatic Cluster Randomised Controlled Trial of Multifaceted Chronic Disease Management Strategies to Improve Diabetes and Hypertension Outcomes in Primary Care. BMC Family Practice. 2014; 15(151): 1-16.

Roslani A.C., Ramakrishnan R., Azmi S., Arapoc D.J., Goh A. Review Article: Use of Renal Registry Data for Research, Healthcare Planning and Quality Improvement. What can We Learn from the Registry Data in the Asia-Pacific Region? BioMed Centre Gastroenterology. 2014; 14(95): 1-7.

Low W.H.H., Seet W., Ramli A.S., Ng K.K., Jamaiyah H., Dan S.P., Teng C.L. et al. Community-based Cardiovascular Risk Factors Intervention Strategies (CORFIS) in Managing Hypertension: a Pragmatic Non-randomised Controlled Trial. Medical Journal Malaysia. 2013; 68(2): 129-135.

Soraya A. Pharmacoeconomics in Malaysia. RIPER ISPOR Oct Bulletin. 2012; 3(27): 7-8.

Selvaraj F.J., Mohamed M., Omar K., Nanthan S., Kusiar Z., Subramaniam S.Y., Low W.H., Ali N., Karanakaran K., Ahmad F. The Impact of a Disease Management Program (COACH) on the Attainment of Better Cardiovascular Risk Control in Dyslipidaemic Patients at Primary Care Centres (The DESSEMINATE Study): a Randomised Controlled Trial. BMC Family Practice. 2012; 13(97).

Yusof F.A. , Goh A. , Azmi S. Estimating an EQ-5D Value Set for Malaysia Using Time Trade-Off and Visual Analogue Scale Methods. Value in Health. 2012; 15: S85 – S90.

Aljunid S., Abuduxike G., Ahmed Z., Sulong S., Nur A.M., Goh A. Impact of routine PCV7 (Prevenar) vaccination of infants on the clinical and economic burden of pneumococcal disease in Malaysia. BMC Infectious Diseases. 2011, 11: 248.

Low W. The CORFIS Experience. Malaysian Family Physician. 2010; 5 (1): 57 – 58.

Faridah A., Jamaiyah H., Goh A., Soraya A. The Validation of the EQ-5D in Malaysian Dialysis Patients. Med J Malaysia. 2010 Jun; 65 (Suppl A).: 114 – 119.

Lim T.O, Goh A., Lim Y.N, Zaher Z.M.M., Suleiman A.B. How Public and Private Reforms Dramatically Improved Access to Dialysis Therapy in Malaysia. Health Affairs. 2010 ; 29 (12): 1 – 9.

Lim T.O, Goh A. Geographic equity in distribution of scarce dialysis resources in Malaysia in Promoting Health and Equity: Evidence, Policy and Action – Cases from the Western Pacific Region WHO Regional Office for the Western Pacific. 2009.

Lim T.O, Goh A., Lim Y.N and Morad, Z. Use of renal registry data for research, healthcare planning and quality improvement. What can we learn from the registry data in the Asia-Pacific region? Nephrology (Carlton). 2008 Dec;13(8):745-52.

Hooi L.S, Lim T.O, Goh A., Wong H.S, Tan C.C, Ghazali A, Zaki M. Economic Evaluation of Centre Haemodialysis and Continuous Ambulatory Peritoneal Dialysis in Ministry of Health Hospitals, Malaysia – Nephrology 2005; 10: 25-32.

Mulhall, JP., McLaughlin, TP., Harnett, JP, Scott B, Burhani S., Russell D. Medication Utilization Behavior in Patients Receiving Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction. Journal of Sexual Medicine. 2005. 2 (6), 848-855.

McLaughlin T, Harnett J, Burhani S., Scott B. Evaluation of erectile dysfunction therapy in patients previously nonadherent to long-term medications: a retrospective analysis of prescription claims. Am J Ther. 2005 Nov-Dec;12(6):605-11.